UK markets open in 3 hours 38 minutes

Biofrontera AG (BFFTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.60000.0000 (0.00%)
At close: 3:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.6000
Open2.6000
BidN/A x N/A
AskN/A x N/A
Day's range2.6000 - 2.6000
52-week range2.6000 - 5.6500
Volume15,000
Avg. volume81
Market cap126.016M
Beta (5Y monthly)1.53
PE ratio (TTM)N/A
EPS (TTM)-0.3220
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Biofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp

    Leverkusen, Germany, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced the approval of the new red-light source for photodynamic therapy (PDT), the BF-RhodoLED® XL, by the U.S. Food and Drug Administration (FDA). In accordance with FDA requirements, the approval was granted as a combination approval with our prescription drug Ameluz®, same as the approval with the predecessor

  • Globe Newswire

    Biofrontera reports preliminary approximate revenues for the month of September 2021

    Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of September 2021. The Company’s preliminary, unaudited revenue from product sales in September 2021 was in the range of EUR 2.3 and 2.5 million, compared to EUR 1.8 million in September 2020, an increase of about 33%. Preliminary revenues from product sales in t

  • Globe Newswire

    Biofrontera reports preliminary revenue for the month of August 2021

    Leverkusen, Germany, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of August 2021. The Company’s preliminary, unaudited revenue from product sales in August 2021 amounted to approximately EUR 1,485 thousand, compared to EUR 1,341 thousand in August 2020, an increase of 11%. Preliminary revenues from product sales in the US were